To validate the association between country-of-birth and disparities in the stimulant use for ADHD among individuals in Western Australia.
Using linked data, a population-based retrospective cohort of individuals admitted to hospital before age 25 years was followed through to identify having stimulants for ADHD in 2003–2007. Multivariate logistic and linear regressions were used to characterise associations between stimulants and country-of-birth, geographical remoteness and socioeconomic status.
Of 679,645 individuals, 14,122 (2.1%) had a record of having stimulants for ADHD. Of these, 205 (1.5%) were born in Africa, Asia, Middle-East or South America, while 13,664 (96.8%) were born in Australia/New Zealand, Europe or North America. Individuals with traditionally non-Anglophonic backgrounds were around one-half as likely to have stimulants as individuals with Anglophonic backgrounds (OR = 0.53, 95% CI 0.46–0.61, p < 0.001). Non-Anglophones were an average of 2.7 years older than Anglophones at onset of having stimulants. Individuals from remote and disadvantaged backgrounds had stimulants at younger ages than individuals living in metropolitan areas and with least disadvantage.
The results highlight the importance of identifying factors underlying cultural differences in stimulant treatment for ADHD. Improving awareness of cultural variations may foster trust and rapport between patients and clinicians, and so better facilitate the appropriate and effective treatment of ADHD for each patient.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington: APA; 2013. CrossRef
Dalsgaard S, Nielsen HS, Simonsen M. Five-fold increase in national prevalence rates of ADHD medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder and other psychiatric disorders. J Child Adolesc Psychopharmacol. 2013;23:432–9. CrossRefPubMedPubMedCentral
Partridge B, Lucke J, Hall W. Over-diagnosed and over-treated: a survey of Australian public attitudes towards the acceptabliity of drug treatment for drepression and ADHD. BMC Psychiatry. 2014;14(74):1–9.
Inpatient Data Collections. Hospital morbidity data system: HMDS reference manual. Western Australia: Department of Health; 2013.
Department of Health. Stimulant prescribing code: clinical criteria for the prescribing of stimulant medicines in Western Australia. Department of Health Western Australia Pharmaceutical Services Branch, Public Health and Clinical Services Division; 2014. http://ww2.health.wa.gov.au/Articles/S_T/Stimulant-medicines. Accessed 6 Mar 2017.
Pharmaceutical Services Branch. Stimulant prescribing and usage patterns for the treatment of ADHD in Western Australia (1 August 2003–31 December 2004). Pharmaceutical Services Branch, Department of Health Western Australia; 2005. http://www.public.health.wa.gov.au/cproot/3609/2/03-04_report.pdf. Accessed 6 Mar 2017.
Australian Bureau of Statistics. Population by age and sex, Western Australia. Canberra: ABS (Cat no. 3235.0); 2013.
Australian Bureau of Statistics. Information paper: an introduction to socio-economic indexes for areas (SEIFA). Canberra: ABS (2006 Cat no 20390); 2008.
Human Relation Area Files e. World Cultures. In: New Haven (CT): eHRAF. 2014. http://ehrafworldcultures.yale.edu.ezproxy.library.uwa.edu.au/ehrafe/regionsCultures.do. Accessed May 2014.
Kleinman A. Rethinking psychiatry. New York: The Free Press; 1988.
David N. ADHD in Indian elementary classrooms: understanding teacher perspectives. Int J Spec Educ. 2013;28(2):1–13.
Wittkampf L, Smeets H, Knol M, Geerlings M, Braam A, DeWit N. Differences in psychotropic drug prescriptions among ethnic groups in the Netherlands. Soc Psychiatry Psychiatric Epidemiol. 2010;45:819–26. CrossRef
Knopf H, Holling H, Huss M, Schlack R. Prevalence, determinants and spectrum of attention-deficit hyperactivity disorder (ADHD) medication of children and adolescents in Germany: results of the German Health Interview and Examination Survey (KiGGS). BMJ Open. 2012;2:1–12. CrossRef
Singh I, Kelleher KJ. Neuroenhancement in young people: proposal for research, policy and clinical management. AJOB Neurosci. 2010;1(1):3–16. CrossRef
Harwood V. The new outsiders: ADHD and disadvantage. In: Graham L, editor. (De) Constructing ADHD: critical guidance for teachers and teacher educatiors. New York: Peter Lang; 2010. p. 119–42.
Prosser B. Attention deficit hyperactivity disorder in Australia: perspectives from the sociology of deviance. J Sociol. 2015;51(3):596–612. CrossRef
- Identifying cross-cultural variations in psychostimulant use for attention deficit hyperactivity disorder using linked data
C. D’Arcy J. Holman
David B. Preen
- BioMed Central
Neu im Fachgebiet Psychiatrie
Meistgelesene Bücher aus dem Fachgebiet
Mail Icon II